PIK3CA and neoplasm: Lastly, activation of signalling molecules did not differ between tumours harbouring different PIK3CA pathogenic mutations (Fig. 3f) nor in tumours harbouring multiple pathogenic alterations of genes belonging to the PIK3CA pathway (Fig. S7).